Market Research Logo

Europe Glaucoma Market and Competitive Landscape – 2017

1. Glaucoma: Disease Overview
1.1. Glaucoma Symptoms
1.2. Glaucoma Etiology
1.3. Glaucoma Diagnosis
1.4. Glaucoma Treatment Options
2. Glaucoma Pipeline Insights
2.1. Glaucoma Phase 3 Clinical Trials
2.2. Glaucoma Phase 2 Clinical Trials
2.3. Glaucoma Phase 1 Clinical Trials
3. Glaucoma Epidemiology Analysis
4. Germany Glaucoma Market Insights
4.1. Marketed Products for Glaucoma in Germany
4.2. Germany Glaucoma Market Size & Forecast
4.3. Germany Glaucoma Product Sales Forecast
4.4. Germany Glaucoma Market Share Analysis
5. France Glaucoma Market Insights
5.1. Marketed Products for Glaucoma in France
5.2. France Glaucoma Market Size & Forecast
5.3. France Glaucoma Product Sales Forecast
5.4. France Glaucoma Market Share Analysis
6. Italy Glaucoma Market Insights
6.1. Marketed Products for Glaucoma in Italy
6.2. Italy Glaucoma Market Size & Forecast
6.3. Italy Glaucoma Product Sales Forecast
6.4. Italy Glaucoma Market Share Analysis
7. Spain Glaucoma Market Insights
7.1. Marketed Products for Glaucoma in Spain
7.2. Spain Glaucoma Market Size & Forecast
7.3. Spain Glaucoma Product Sales Forecast
7.4. Spain Glaucoma Market Share Analysis
8. UK Glaucoma Market Insights
8.1. Marketed Products for Glaucoma in UK
8.2. UK Glaucoma Market Size & Forecast
8.3. UK Glaucoma Product Sales Forecast
8.4. UK Glaucoma Market Share Analysis
9. Europe Glaucoma Market Insights
9.1. Europe Glaucoma Market Size & Forecast
9.2. Europe Glaucoma Product Sales Forecast
9.3. Europe Glaucoma Market Share Analysis
10. Research Methodology
LIST OF TABLES
Table 1: Glaucoma Phase 3 Clinical Trials, Global, 2017
Table 2: Glaucoma Phase 2 Clinical Trials, Global, 2017
Table 3: Glaucoma Phase 1 Clinical Trials, Global, 2017
Table 4: Glaucoma Prevalence by EU5 Countries, 2012 - 2021
Table 5: Marketed Products for Glaucoma in Germany, 2017
Table 6: Germany Glaucoma Market Size & Forecast ($mn), 2012 - 2021
Table 7: Germany Glaucoma Product Sales ($mn), 2012 - 2021
Table 8: Germany Glaucoma Market Trends, 2012 - 2021
Table 9: Marketed Products for Glaucoma in France, 2017
Table 10: France Glaucoma Market Size & Forecast ($mn), 2012 - 2021
Table 11: France Glaucoma Product Sales ($mn), 2012 - 2021
Table 12: France Glaucoma Market Trends, 2012 - 2021
Table 13: Marketed Products for Glaucoma in Italy, 2017
Table 14: Italy Glaucoma Market Size & Forecast ($mn), 2012 - 2021
Table 15: Italy Glaucoma Product Sales ($mn), 2012 - 2021
Table 16: Italy Glaucoma Market Trends, 2012 - 2021
Table 17: Marketed Products for Glaucoma in Spain, 2017
Table 18: Spain Glaucoma Market Size & Forecast ($mn), 2012 - 2021
Table 19: Spain Glaucoma Product Sales ($mn), 2012 - 2021
Table 20: Spain Glaucoma Market Trends, 2012 - 2021
Table 21: Marketed Products for Glaucoma in UK, 2017
Table 22: UK Glaucoma Market Size & Forecast ($mn), 2012 - 2021
Table 23: UK Glaucoma Product Sales ($mn), 2012 - 2021
Table 24: UK Glaucoma Market Trends, 2012 - 2021
Table 25: Europe Glaucoma Market Size & Forecast ($mn), 2012 - 2021
Table 26: Europe Glaucoma Product Sales ($mn), 2012 - 2021
LIST OF FIGURES
Figure 1: Glaucoma Pipeline by Phase (%), Global, 2017
Figure 2: Glaucoma Prevalence by EU5 Countries, 2012 - 2021
Figure 3: Germany Glaucoma Market Size ($mn), 2012 - 2021
Figure 4: Germany Glaucoma Product Sales ($mn), 2012 - 2021
Figure 5: Germany Glaucoma Market Share by Products (%), 2016
Figure 6: Germany Glaucoma Market - Future Market Share (%), 2021
Figure 7: France Glaucoma Market Size ($mn), 2012 - 2021
Figure 8: France Glaucoma Product Sales ($mn), 2012 - 2021
Figure 9: France Glaucoma Market Share by Products (%), 2016
Figure 10: France Glaucoma Market - Future Market Share (%), 2021
Figure 11: Italy Glaucoma Market Size ($mn), 2012 - 2021
Figure 12: Italy Glaucoma Product Sales ($mn), 2012 - 2021
Figure 13: Italy Glaucoma Market Share by Products (%), 2016
Figure 14: Italy Glaucoma Market - Future Market Share (%), 2021
Figure 15: Spain Glaucoma Market Size ($mn), 2012 - 2021
Figure 16: Spain Glaucoma Product Sales ($mn), 2012 - 2021
Figure 17: Spain Glaucoma Market Share by Products (%), 2016
Figure 18: Spain Glaucoma Market - Future Market Share (%), 2021
Figure 19: UK Glaucoma Market Size ($mn), 2012 - 2021
Figure 20: UK Glaucoma Product Sales ($mn), 2012 - 2021
Figure 21: UK Glaucoma Market Share by Products (%), 2016
Figure 22: UK Glaucoma Market - Future Market Share (%), 2021
Figure 23: Europe Glaucoma Market Size ($mn), 2012 - 2021
Figure 24: Europe Glaucoma Product Sales ($mn), 2012 - 2021
Figure 25: Europe Glaucoma Market Share by Products (%), 2016
Figure 26: Europe Glaucoma Market - Future Market Share (%), 2021

Europe Glaucoma Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Europe Glaucoma Market and Competitive Landscape – 2017, provides comprehensive insights into Glaucoma pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Glaucoma market size and drug sales. This research also provides insights into Glaucoma epidemiology and late stage pipeline.
The report is classified into nine sections – Glaucoma overview with definitions, symptoms, etiology, diagnosis, treatment options; Glaucoma pipeline insights covering late stage clinical trials pipeline; Glaucoma prevalence trends by countries; Glaucoma market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries – Germany, France, Italy, Spain, UK, Europe.

Research Scope:

  • Glaucoma pipeline: Find out the drugs in clinical trials for Glaucoma by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Glaucoma epidemiology: Find out the prevalence of Glaucoma by countries – Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Glaucoma products: Identify key products marketed and prescribed for Glaucoma by brand name, by molecule, by company, by branded / generic, by countries – Europe, Germany, France, Italy, Spain, UK, Japan
  • Glaucoma market size: Find out the market size for Glaucoma drugs by countries – Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Glaucoma drug sales: Find out the sales of Glaucoma drugs by countries – Europe, Germany, France, Italy, Spain, UK
  • Glaucoma drugs sales forecast: Sales forecast for Glaucoma drugs to 2021 by countries – Europe, Germany, France, Italy, Spain, UK, Japan
  • Glaucoma market share analysis: Find out the market shares of Glaucoma drugs and outlook by countries – Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Glaucoma drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Glaucoma market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Glaucoma market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;